ArticleCancers2025

How Many Patients with Choroidal Melanoma Would Be Eligible for Neoadjuvant Systemic Therapy to Enable Ruthenium-106 Brachytherapy?

Bertil Damato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.